On the occasion of The Prophet's Birthday, all our Centres will be closed on Friday, 29 September.
In 2021, Imperial College London Diabetes Centre (ICLDC) has been approved as a Centre of Excellence by the International Diabetes Federation (IDF). It joins a prestigious global network of diabetes institutions that initiates, coordinates, facilitates and conducts holistic diabetes services and multidisciplinary education in diabetes and related chronic diseases.
In 2021 Imperial College London Diabetes Centre has become the first in Abu Dhabi and the third in the UAE to be accredited as a Collaborating Centre for Obesity Management (COM) by the European Association for the Study of Obesity (EASO). Under the EASO COM scheme, obesity management centres are accredited against a set of stringent criteria and in accordance with accepted European and academic guidelines to ensure consistently high standards in different countries across the world.
Imperial College London Diabetes Centre holds the highly prestigious Joint Commission International (JCI) accreditation and certification for high standards of care at the Centre’s two locations in Abu Dhabi and Al Ain.
The JCI Gold Seal of Approval®, represents a symbol of quality that reflects an organisation’s commitment to providing safe and effective patient care and is highly regarded by the healthcare sector.
Imperial College London Diabetes Centre has been at the forefront of international accreditation in the country since it became the first healthcare provider worldwide in 2010 to receive both the JCI Clinical Care Program Certification (CCPC) for Diabetes Management and the JCI Accreditation for Ambulatory Care. At the same time, it also became the first facility in the Middle East and the third around the world to hold JCI’s highly-acclaimed CCPC specifically for the clinical management of diabetes. The Centres in Abu Dhabi and Al Ain were reaccredited in February 2022.
The CAP Laboratory Accreditation program is a worldwide leader in laboratory quality assurance, improving patient safety by ensuring laboratories meet or exceed regulatory requirements. CAP has accredited NRL managed laboratory in Imperial College London Diabetes Center.